Purpose: To report and characterize ocular features of asymptomatic vitreoretinal lymphoma (VRL) associated with primary central nervous system lymphoma (PCNSL), by examining clinical and multimodal imaging characteristics and comparing with symptomatic VRL.
Design: Retrospective cross-sectional study.
Methods: Patients with cytologically or molecularly confirmed VRL were included. Patients were classified into three groups: primary VRL (PVRL), symptomatic VRL associated with PCNSL (PCNSL-S), or asymptomatic VRL associated with PCNSL (PCNSL-AS). Data encompassing demographics, visual symptoms, visual acuity (VA), and imaging characteristics were collected. Cross-sectional analyses of quantitative and categorical variables among groups were performed with one-way ANOVA and multinomial linear regression analyses.
Results: The study included 104 eyes from 56 patients with VRL. Twenty-nine patients (52%) were diagnosed with PVRL, and 27 patients (48%) were diagnosed with VRL associated with PCNSL. Among these, 17 (63%) reported visual symptoms (PCNSL-S), whereas 10 (37%) were asymptomatic (PCNSL-AS). PCNSL-AS patients exhibited better VA than PVRL patients (0.11 vs 0.76 LogMAR, P = 0.04) and distinct clinical features, with lower rates of anterior segment involvement (odds ratio [OR] = 0.02; 95% confidence interval [CI] 0.12-0.84; P < .01) and vitritis (OR = 0.32; 95% CI 0.11-0.91; P = .03). Subretinal infiltration was less common in PCNSL-AS cases compared to PVRL (OR = 0.14; 95% CI 0.02-1.11; P = 0.06) and PCNSL-S (OR: 0.08; 95% CI 0.01-0.69 P = 0.05) and was associated with worse VA (estimate = 0.55 LogMAR; 95% CI 0.29-0.8; P < .01).
Conclusions: This study describes distinctive clinical and imaging features of asymptomatic VRL associated with PCNSL, characterized by better VA and less severe ocular involvement. The findings highlight the pivotal role of multimodal imaging in facilitating early detection of VRL in the staging of PCNSL. Future guidelines for PCNSL management should consider the necessity of diagnosing patients with asymptomatic VRL.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2024.07.004 | DOI Listing |
Graefes Arch Clin Exp Ophthalmol
December 2024
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Purpose: The purpose of this study was to evaluate Retromode (Nidek Co., Gamagori, Japan) as an adjunct diagnostic tool in vitreoretinal lymphoma (VRL). By integrating Retromode findings with multimodal imaging, we aimed to enhance lesion detection of VRL lesions in the retina.
View Article and Find Full Text PDFViruses
October 2024
Institute of Virology, Free University, 14163 Berlin, Germany.
Adeno-associated viruses (AAV) are widely used as delivery vectors in clinical trials for in vivo gene therapy due to their unique features. Göttingen minipigs are a well-established animal model for several diseases and can be used for the efficacy and safety testing of AAV-based gene therapy. Pre-existing antibodies against AAV may influence the results of testing and, therefore, the animals should be tested for the presence of antibodies against relevant AAV serotypes.
View Article and Find Full Text PDFBr J Ophthalmol
October 2024
Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Aims: To investigate the significance of regulatory T cells (Tregs) and programmed cell death 1 (PD-1) cytotoxic T lymphocytes (CTLs) in the vitreous of patients with vitreoretinal lymphoma (VRL) and uveitis.
Methods: This study involved 51 patients with VRL and uveitis, 15 males and 36 females (mean age: 72 years, range: 51-86 years), who underwent vitrectomy at the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, from December 2019 to February 2024. All patients underwent lymphocyte surface antigen analysis via flow cytometry, and the proportion of Tregs in CD4 T lymphocytes and PD-1 CTLs in CD8 T lymphocytes was measured.
Retina
October 2024
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; and.
Purpose: To identify demographic and clinical factors associated with delayed diagnosis in patients with primary vitreoretinal lymphoma (VRL).
Methods: Retrospective, tertiary referral center-based cohort study of all patients at Mayo Clinic in Rochester, Minnesota, with a biopsy-proven diagnosis of VRL from January 1, 2000, to October 31, 2022.
Results: There were 87 patients included during the 22-year study period with 73 patients (83.
Am J Ophthalmol
November 2024
From the School of Medicine, Vita-Salute San Raffaele University, Milan, Italy (M.M., M.V.C., M.C.R., A.M., G.M., F.B., E.M.); Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy (M.M., M.V.C., M.C.R., A.M., G.M., F.B., E.M.). Electronic address:
Purpose: To report and characterize ocular features of asymptomatic vitreoretinal lymphoma (VRL) associated with primary central nervous system lymphoma (PCNSL), by examining clinical and multimodal imaging characteristics and comparing with symptomatic VRL.
Design: Retrospective cross-sectional study.
Methods: Patients with cytologically or molecularly confirmed VRL were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!